Ryan Merket
Angel Investor
San Francisco, United States
Ryan Merket is a seed investor in San Francisco focused on Artificial Intelligence and E-Commerce. Ryan Merket is based out of Austin, Texas and is the Founding Editor of RuntimeWire. Ryan previously worked at Microsoft as a CTO - Microsoft for Startups. Ryan Merket attended the Oklahoma Wesleyan University.
- Total investments:
- 38
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Ryan Merket invests in
Stages Ryan Merket invests in
Countries Ryan Merket invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $1.1M–$14M
- Pre-Seed
- $120k–$500k
- Venture - Series Unknown
- $250k–$12M
Investment Focus
Industry
- Artificial Intelligence 8 (21%)
- E-Commerce 5 (13%)
- Apps 4 (11%)
- Software 4 (11%)
- Biotechnology 4 (11%)
Stage
- Seed 20 (53%)
- Pre-Seed 14 (37%)
- Venture - Series Unknown 2 (5%)
- Angel 1 (3%)
- Series A 1 (3%)
Country
- United States 34 (89%)
- United Kingdom 2 (5%)
- Canada 1 (3%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Revision Dojo uses AI to transform study tools like question banks, notes, and mini-lessons into personalized learning experiences. | $3.4M / Seed / Mar 16, 2025 | ||
| emojis.com empowers small businesses with an AI graphic designer to create their brand identity without high costs. | $500K / Pre-Seed / Mar 12, 2025 | ||
| a0.dev enables mobile developers to efficiently create high-quality applications by generating customized React Native projects. | $500K / Pre-Seed / Mar 12, 2025 | ||
| Bindwell is a Biotech company that uses AI to develops safer pesticides. | $500K / Pre-Seed / Mar 12, 2025 | ||
| Exla employs quantization techniques for AI models to reduce memory consumption while simultaneously improving inference speed. | $500K / Pre-Seed / Mar 12, 2025 | ||
| Exin Therapeutics is developing a discovery platform for next-generation genetic therapies targeting dysregulated neural circuits across disorders, and next-generation neurotherapeutics leverage advancements in genetics, technology, and engineering to create innovative treatments for neurological disorders. These therapies, which include genetherapy, nucleotide-based therapeutics, and cell-based therapies, address previously untreatable disease mechanisms and unmet medical needs. | $500K / Pre-Seed / Jan 21, 2025 | ||
| Fuse is an energy supplier that offers the UK's cheapest electricity tarif. Also active in the US. | $12M / Venture - Series Unknown / Sep 17, 2024 | ||
| Fizz is building a debit card that helps college students in the U.S. started building out their credit without having to learn lessons about overzealous credit use the hard way. | $14.4M / Seed / Jun 06, 2024 | ||
| Datacurve Providing code data validated by engineers, allowing you to design the most competent model or application | $500K / Pre-Seed / Mar 01, 2024 | ||
| Blossm is a community marketplace to buy, sell, and trade plants. It aims to connect plant enthusiasts in the community through a shared passion for plants. Blossm was founded in 2020 and is based in San Diego, California. | $120K / Pre-Seed / Jan 13, 2023 | ||
| See all 38 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Ryan Merket invest in?
Ryan Merket invests primarily in Artificial Intelligence, E-Commerce and Apps startups, most often at Seed and Pre-Seed stage. Most of the 38 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Ryan Merket invest in?
Ryan Merket typically joins rounds of $1.1M–$14M at Seed, $120k–$500k at Pre-Seed and $250k–$12M at Venture - Series Unknown. These are whole funding-round sizes, not Ryan Merket's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Ryan Merket took part in.
How do I contact Ryan Merket?
Public channels for Ryan Merket include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Ryan Merket last invest?
The most recent investment recorded for Ryan Merket closed in Mar 2025. Shizune tracks 38 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
